• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗葡萄膜炎模式:系统评价。

Pattern of Uveitis in Iran: A Systematic Review.

作者信息

Bagheri Masood, Ahoor Mohammad-Hosein, Jafari Ahad, Hashemi Hesam Sadat, Mohammadkhani Mehdi

机构信息

Department of Ophthalmology, Imam Khomeini Eye Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.

Department of Ophthalmology, Nikookari Eye Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

J Ophthalmic Vis Res. 2021 Jan 20;16(1):93-102. doi: 10.18502/jovr.v16i1.8255. eCollection 2021 Jan-Mar.

DOI:10.18502/jovr.v16i1.8255
PMID:33520132
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7841267/
Abstract

PURPOSE

Uveitis is the third leading cause of blindness worldwide. This study aimed to summarize the pattern of uveitis in Iran through a systematic review.

METHODS

This review was conducted according to the guidelines for systematic reviews in the following four steps: literature search, study selection and assessment, inclusion and exclusion criteria, and statistical analysis.

RESULTS

One hundred and fifteen articles were identified by an encyclopedic literature search, and three independent investigators examined them according to the defined inclusion and exclusion criteria. Eventually, 109 manuscripts were retrieved and six cross-sectional studies covering 3,567 patients were included and reviewed. According to the results, the mean age of patients was 40 years, and sex was not a statistically significant predisposing factor. The most common anatomical pattern of involvement was anterior uveitis, and the prevalence of the other three types of uveitis, including middle, posterior, and pan-uveitis, were almost equal. Overall, the most common etiologies of uveitis in the Iranian population were idiopathic uveitis, toxoplasmosis, Behcet's syndrome, and Fuchs heterochromic iridocyclitis.

CONCLUSION

This study depicted the pattern of uveitis in the Iranian society; this can help physicians in the diagnostic approach, management, and treatment of patients.

摘要

目的

葡萄膜炎是全球第三大致盲原因。本研究旨在通过系统评价总结伊朗葡萄膜炎的发病模式。

方法

本评价按照系统评价指南分以下四个步骤进行:文献检索、研究选择与评估、纳入与排除标准以及统计分析。

结果

通过全面的文献检索确定了115篇文章,由三名独立研究人员根据既定的纳入和排除标准对其进行审查。最终,检索到109篇手稿,纳入并审查了6项横断面研究,涵盖3567例患者。根据结果,患者的平均年龄为40岁,性别不是具有统计学意义的易感因素。最常见的受累解剖模式是前葡萄膜炎,其他三种葡萄膜炎类型(包括中间葡萄膜炎、后葡萄膜炎和全葡萄膜炎)的患病率几乎相等。总体而言,伊朗人群中葡萄膜炎最常见的病因是特发性葡萄膜炎、弓形虫病、白塞病和富克斯异色性虹膜睫状体炎。

结论

本研究描绘了伊朗社会葡萄膜炎的发病模式;这有助于医生对患者进行诊断、管理和治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c04/7841267/95cb1ac046dd/jovr-16-93-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c04/7841267/ef67e6d83293/jovr-16-93-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c04/7841267/95cb1ac046dd/jovr-16-93-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c04/7841267/ef67e6d83293/jovr-16-93-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0c04/7841267/95cb1ac046dd/jovr-16-93-g002.jpg

相似文献

1
Pattern of Uveitis in Iran: A Systematic Review.伊朗葡萄膜炎模式:系统评价。
J Ophthalmic Vis Res. 2021 Jan 20;16(1):93-102. doi: 10.18502/jovr.v16i1.8255. eCollection 2021 Jan-Mar.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Patterns of uveitis in a tertiary eye care center in Iran.伊朗一家三级眼科护理中心的葡萄膜炎模式。
Ocul Immunol Inflamm. 2004 Dec;12(4):297-310. doi: 10.1080/092739490500174.
4
Clinical Patterns of Uveitis in an Iranian Tertiary Eye-care Center.伊朗一家三级眼科护理中心葡萄膜炎的临床模式
Ocul Immunol Inflamm. 2015 Aug;23(4):278-282. doi: 10.3109/09273948.2014.902474. Epub 2014 Apr 16.
5
Pattern and Visual Prognostic Factors of Behcet's Uveitis in Northwest Iran.伊朗西北部白塞氏葡萄膜炎的发病模式及视觉预后因素
J Ophthalmic Vis Res. 2022 Apr 29;17(2):242-251. doi: 10.18502/jovr.v17i2.10796. eCollection 2022 Apr-Jun.
6
Characteristics of uveitic glaucoma in Turkish patients.土耳其患者葡萄膜炎相关性青光眼的特征。
Eur J Ophthalmol. 2021 Jul;31(4):1836-1843. doi: 10.1177/1120672120950932. Epub 2020 Aug 17.
7
Uveitis in childhood.儿童葡萄膜炎
J Pediatr Ophthalmol Strabismus. 2003 Nov-Dec;40(6):335-40. doi: 10.3928/0191-3913-20031101-06.
8
Features of hemodynamic and immunological parameters in patients with recurrent uveitis complicated by hypertension, Fuchs heterochromic uveitis and Posner-Schlossman syndrome.反复发作性葡萄膜炎合并高血压、Fuchs 异色性虹膜睫状体炎和 Posner-Schlossman 综合征患者的血流动力学和免疫参数特征。
Rom J Ophthalmol. 2023 Jan-Mar;67(1):20-32. doi: 10.22336/rjo.2023.5.
9
Aetiology and clinical characteristics of uveitic glaucoma in Turkish patients.土耳其患者葡萄膜炎相关性青光眼的病因和临床特征。
Int Ophthalmol. 2021 Jun;41(6):2225-2234. doi: 10.1007/s10792-021-01783-4. Epub 2021 Mar 17.
10
Demographic and clinical features of uveitis in tertiary centers in Turkey.土耳其三级医疗中心葡萄膜炎的人口统计学和临床特征。
Ophthalmic Epidemiol. 2008 Sep-Oct;15(5):285-93. doi: 10.1080/09286580802262821.

引用本文的文献

1
Shedding light on pharmacoepidemiology of eye diseases: a cohort study in Western Iran.揭示眼病的药物流行病学:伊朗西部的一项队列研究
Sci Rep. 2025 Jul 9;15(1):24733. doi: 10.1038/s41598-025-09889-w.
2
Epidemiology of Uveitis from a Tertiary Referral Hospital in Bulgaria over a 13-Year Period.保加利亚一家三级转诊医院13年期间葡萄膜炎的流行病学情况
Diagnostics (Basel). 2025 Mar 25;15(7):828. doi: 10.3390/diagnostics15070828.
3
Protective effect of early immunomodulatory treatment on ocular involvement in Behcet's disease: Historical cohort of 1166 patients.

本文引用的文献

1
Patterns of Uveitis at a Tertiary Referral Center in Northeastern Iran.伊朗东北部一家三级转诊中心的葡萄膜炎模式。
J Ophthalmic Vis Res. 2018 Apr-Jun;13(2):138-143. doi: 10.4103/jovr.jovr_67_17.
2
Adalimumab in Patients with Active Noninfectious Uveitis.阿达木单抗治疗活动性非感染性葡萄膜炎患者的疗效。
N Engl J Med. 2016 Sep 8;375(10):932-43. doi: 10.1056/NEJMoa1509852.
3
Demographic and Clinical Features of Pediatric Uveitis at a Tertiary Referral Center in Iran.伊朗一家三级转诊中心小儿葡萄膜炎的人口统计学和临床特征
早期免疫调节治疗对贝赫切特病眼部受累的保护作用:1166例患者的历史队列研究
Heliyon. 2023 Sep 9;9(9):e19981. doi: 10.1016/j.heliyon.2023.e19981. eCollection 2023 Sep.
4
Pattern of Uveitis in a Tertiary Hospital in North Jordan and the Impact of Behcet's Disease.约旦北部一家三级医院的葡萄膜炎模式及白塞病的影响
J Ophthalmol. 2023 Aug 8;2023:2076728. doi: 10.1155/2023/2076728. eCollection 2023.
5
Pattern and Visual Prognostic Factors of Behcet's Uveitis in Northwest Iran.伊朗西北部白塞氏葡萄膜炎的发病模式及视觉预后因素
J Ophthalmic Vis Res. 2022 Apr 29;17(2):242-251. doi: 10.18502/jovr.v17i2.10796. eCollection 2022 Apr-Jun.
Middle East Afr J Ophthalmol. 2016 Jul-Sep;23(3):237-40. doi: 10.4103/0974-9233.186096.
4
A Focus on the Epidemiology of Uveitis.关注葡萄膜炎的流行病学。
Ocul Immunol Inflamm. 2018;26(1):2-16. doi: 10.1080/09273948.2016.1196713. Epub 2016 Jul 28.
5
Infliximab Versus Adalimumab in the Treatment of Refractory Inflammatory Uveitis: A Multicenter Study From the French Uveitis Network.英夫利昔单抗与阿达木单抗治疗难治性葡萄膜炎:法国葡萄膜炎网络的多中心研究。
Arthritis Rheumatol. 2016 Jun;68(6):1522-30. doi: 10.1002/art.39667.
6
The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management.眼免疫与葡萄膜炎基金会葡萄膜炎治疗的优选实践模式。
Surv Ophthalmol. 2016 Jan-Feb;61(1):1-17. doi: 10.1016/j.survophthal.2015.07.001. Epub 2015 Jul 9.
7
A basic introduction to fixed-effect and random-effects models for meta-analysis.Meta 分析中固定效应模型和随机效应模型的基本介绍。
Res Synth Methods. 2010 Apr;1(2):97-111. doi: 10.1002/jrsm.12. Epub 2010 Nov 21.
8
Critical appraisal and data extraction for systematic reviews of prediction modelling studies: the CHARMS checklist.预测模型研究系统评价的严格评价与数据提取:CHARM 清单
PLoS Med. 2014 Oct 14;11(10):e1001744. doi: 10.1371/journal.pmed.1001744. eCollection 2014 Oct.
9
Patterns of uveitis at a tertiary referral center in southern iran.伊朗南部一家三级转诊中心的葡萄膜炎模式
J Ophthalmic Vis Res. 2014 Jan;9(1):54-9.
10
Clinical Patterns of Uveitis in an Iranian Tertiary Eye-care Center.伊朗一家三级眼科护理中心葡萄膜炎的临床模式
Ocul Immunol Inflamm. 2015 Aug;23(4):278-282. doi: 10.3109/09273948.2014.902474. Epub 2014 Apr 16.